The BenchSci Blog

Artificial Intelligence in Drug Discovery Aug 14, 2018
Naheed Kurji, CEO of Cyclica, on Building an AI Platform to Design, Screen, and Personalize Drugs
Artificial Intelligence in Drug Discovery Aug 7, 2018
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Artificial Intelligence in Drug Discovery Aug 7, 2018
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
BenchSci Case Studies Jul 31, 2018
Stephanie Guerra on Antibodies for Characterizing Novel Combination Therapies for KRAS-mutant Lung Adenocarcinoma
Artificial Intelligence in Drug Discovery Jul 30, 2018
Regina Barzilay on AI for Small Molecule Discovery and Synthesis
Artificial Intelligence in Drug Discovery Jul 26, 2018
Tim Guilliams and David Brown, Healx, on AI for Rare Diseases
Artificial Intelligence in Drug Discovery Jul 18, 2018
John Cassidy, CEO of Cambridge Cancer Genomics, on AI-Powered Disease Prediction for Oncology
Artificial Intelligence in Drug Discovery Jul 10, 2018
Kristen Fortney, CEO of BioAge Labs, on AI for Aging Research
Antibody Applications Jun 28, 2018
Immunohistochemistry (IHC): Principles & Factors to Consider For Quality Results
Artificial Intelligence in Drug Discovery Jun 28, 2018
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Artificial Intelligence in Drug Discovery Jun 20, 2018
Shai Shen-Orr, Chief Scientist of CytoReason, on AI for Systems Immunology
Artificial Intelligence in Drug Discovery Jun 11, 2018
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics

Never miss a blog post